Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2681-2686

  Costa, John J ^a   Demetri, George D ^b   Harrist, Terence J ^a,c   Dvorak, Ann M ^a   Hayes, Daniel F ^b   Merica, Elizabeth A ^b   Menchaca, Dora M ^d   Gringeri, Anthony J ^d   Schwartz, Lawrence B ^e   Galli, Stephen J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Pathology Services Inc Cambridge   (United States)

^d AMGEN INC   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; RECOMBINANT STEM CELL FACTOR;

ANAPHYLAXIS; ARTICLE; BREAST CARCINOMA; CELL HYPERPLASIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MAST CELL; MAST CELL DEGRANULATION; MELANOCYTE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTO ONCOGENE; URTICARIA;

ANAPHYLAXIS; BIOPSY; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERPLASIA; MAST CELLS; MELANOCYTES; NEOPLASM STAGING; RECOMBINANT PROTEINS; SKIN; STEM CELL FACTOR;

EID: 15844427770     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2681     Document Type: Article

References (27)

1. Besmer, P. 1991. The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr. Opin. Cell Biol. 3:939-946.
2. Williams, D.E., P. de Vries, A.E. Namen, M.B. Widmer, and S.D. Lyman. 1992. The Steel factor. Dev. Biol. 151:368-376.
3. Galli, S.J., K.M. Zsebo, and E.N. Geissler. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55:1-96.
4. Morstyn, G., S. Brown, M. Gordon, J. Crawford, G. Demetri, W. Rich, B. McGuire, M.A. Foote, and I. McNiece. 1994. Stem cell factor is a potent synergistic factor in hematopoiesis. Oncology. 51:205-214.
5. Tsai, M., L.-S. Shih, G.F.J. Newlands, T. Takeishi, K.E. Langley, K.M. Zsebo, H.R.P. Miller, E.N. Geissler, and S.J. Galli. 1991. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry and protease phenotype. J. Exp. Med. 174:125-131.
6. Galli, S.J., A. Iemura, D.S. Garlick, C. Gamba-Vitalo, K.M. Zsebo, and R.G. Andrews. 1993. Reversible expansion of primate mast cell populations in vivo by stem cell factor. J. Clin. Invest. 91:148-152.
7. Kirshenbaum, A.S., J.P. Goff, S.W. Kessler, J.M. Mican, K.M. Zsebo, and D.D. Metcalfe. 1992. Effect of IL-3 and stem cell factor on the appearance of human basophil and mast cells from CD34+ pluripotent progenitor cells. J. Immunol. 148:772-777.
8. Valent, P., E. Spanblochl, W.R. Sperr, C. Sillaber, K.M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 80:2237-2245.
9. Irani, A.-M.A., G. Nilsson, U. Mettinen, S.S. Craig, L.K. Ashman, T. Ishizaka, K.M. Zsebo, and L.B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed fetal liver cells. Blood. 80: 3009-3021.
10. Mitsui, H., T. Furitsu, A.M. Dvorak, A.-M.A. Irani, L.B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K.M. Zsebo, S. Gillis, and T. Ishizaka. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Prof. Natl. Acad. Sci. USA. 90:735-739.
11. Wershil, B.K., M. Tsai, E.N. Geissler, K.M. Zsebo, and S.J. Galli. 1992. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function. J. Exp. Med. 175:245-255.
12. Columbo, M., E.M. Horowitz, L.M. Botana, D.W.J. Mac-Glashan, B.S. Bochner, S. Gillis, K.M. Zsebo, S.J. Galli, and L.M. Lichtenstein. 1992. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 149:599-608.
13. Funasaka, Y., T. Boulton, M. Cobb, Y. Yarden, B. Fan, S.D. Lyman, D.E. Williams, D.M. Anderson, R. Zakut, Y. Mishima, and R. Halaban. 1992. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol. Biol. Cell. 3:197-209.
14. Costa, J.J., G.D. Demetri, D.F. Hayes, E.A. Merica, D.M. Menchaca, and S.J. Galli. 1993. Increased skin mast cells and urine methyl histamine in patients receiving recombinant methionyl human stem cell factor. Proc. Am. Assoc. Cancer Res. 34:211. (Abstr.)
15. Costa, J.J., G.D. Demetri, T.J. Harrist, A.M. Dvorak, D.F. Hayes, E.A. Merica, D.M. Menchaca, A.J. Gringeri, and S.J. Galli. 1994. Recombinant human stem cell factor (rhSCF) induces cutaneous mast cell activation and hyperplasia, and hyperpigmentation in humans in vivo. J. Allergy Clin. Immunol. 93:225. (Abstr.)
16. Sheehan, D.C., and B.B. Hrapchak. 1980. Theory and Practice of Histotechnology. 2nd ed. C.V. Mosby, St. Louis, MO. 481 pp.
17. Rhodes, A.R., T.J. Harrist, and T.K. Momtaz. 1983. The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes. J. Am. Acad. Dermatol. 9:47-58.
18. Dvorak, A.M. 1992. Human mast cells. Ultrastructural observations of in situ, ex vivo and in vitro sites, sources and systems. In The Mast Cell in Health and Disease. M.A. Kaliner and D.D. Metcalfe, editors. Marcel Dekker, New York. 1-90.
19. Keyzer, J.J., J.G.R. de Monchy, J.J. van Doormaal, and P.C. van Voorst Vader. 1983. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites. N. Engl. J. Med. 309:1603-1605.
20. Schwartz, L.B., K. Sakai, T.R. Bradford, S. Ren, B. Zweiman, A.S. Worobec, and D.D. Metcalfe. 1995. The a form of human tryptase is the predominant type present in blood at baseline in normal subjects, and is elevated in those with systemic mastocytosis. J. Clin. Invest. 96:2702-2710.
21. Schwartz, L.B., T.R. Bradford, C. Rouse, A.-M. Irani, G. Rasp, J.K. Van der Zwan, and P.W.G. Van Der Linden. 1994. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol. 14:190-204.
22. Miller, A.B., B. Hoogstraten, M. Staquet, and A. Winkler. 1981. Reporting results of cancer treatment. Cancer. 47:207-214.
23. Mekori, Y.A., C.K. Oh, and D.D. Metcalfe. 1993. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J. Immunol. 151:3775-3784.
24. Yee, N.S., I. Paek, and P. Besmer. 1994. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of White spotting and Steel mutant mice. J. Exp.Med. 179:1777-1787.
25. Iemura, A., M. Tsai, A. Ando, B.K. Wershil, and S.J. Galli. 1994. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am. J. Pathol. 144:321-328.
26. Kwan, T.H. 1990. Hypermelanosis. In Pathology of the Skin. E.R. Farmer and A.F. Hood, editors. Appelton and Lange, Norwalk, CT. 160-172.
27. Longley, B.J.J., G.S. Morganroth, L. Tyrrell, T.G. Ding, D.M. Anderson, D.E. Williams, and R. Halaban. 1993. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N. Engl. J. Med. 328:1302-1307.